Seagen
SGEN
$228.74
Share price
-0.07%
Change (1 day)
68.92%
Change (1 year)
Categories
Seagen (SGEN) Fails to deliver data
Key failure to deliver metrics for Seagen :
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: N/A
- Last year FTD volume: $38.78 M
Failures to deliver for Seagen (SGEN) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Seagen (SGEN) - since 2020
Volume in USD (price x number of shares), data since 2020Seagen (SGEN) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2023 | $52.96 M | -33.99% |
| 2022 | $80.23 M | 43.67% |
| 2021 | $55.84 M | 83.78% |
| 2020 | $30.38 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Pfizer PFE | $31.87 M | $0.32 B | 🇺🇸 USA |
 AbbVie ABBV | $8.76 M | $0.15 B | 🇺🇸 USA |
 Biogen BIIB | $17.8 M | $72.14 M | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $0.19 B | $0.29 B | 🇺🇸 USA |
 GlaxoSmithKline GSK | $15.53 M | $26.02 M | 🇬🇧 UK |
 Spectrum Pharmaceuticals
SPPI | N/A | $0.44 M | 🇺🇸 USA |
 ImmunoGen
IMGN | $8.25 M | $25.26 M | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $0.8 M | $3.83 M | 🇺🇸 USA |